EP4265299A2 — Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection
Assigned to Gilead Sciences Inc · Expires 2023-10-25 · 3y expired
What this patent protects
The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb):which are useful in the treatment of a Retroviridae viral infection including an infection caused by the HIV virus.
USPTO Abstract
The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb):which are useful in the treatment of a Retroviridae viral infection including an infection caused by the HIV virus.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.